Notify me when Peter Greenleaf files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Chief Executive Officer, Director | $29,428,340 | -$2,871,124 | -8.9% | 02 Jan 2026 |
| ATRS | ANTARES PHARMA, INC. | Director | 24 May 2022 | |||
| BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Director | 22 Mar 2022 | |||
| CHRO | Channel Therapeutics Corp | Director | 02 Jul 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|